Trials / Unknown
UnknownNCT02806128
The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Huisheng Chen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the effectiveness of the of kallikrein in the different drug frequency for acute anterior circulation cerebral infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Human Urinary Kallidinogenase for Injection | Patients need to complete laboratory tests within a specified time and to complete the experimental requirements of medication time |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-12-01
- First posted
- 2016-06-20
- Last updated
- 2017-01-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02806128. Inclusion in this directory is not an endorsement.